Trial Profile
Early ultrasonography role by Contrast enhanced ultrasonography ( CEUS) evaluating therapy effectiveness in patients with hepatic metastasis of colorectal cancer treated with antiangiogenetic drug.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2014
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Diagnostic use
- 27 Jun 2014 New trial record